WCN26-4970 Plasma Cell-Rich Acute Rejection in a Young Kidney Transplant Patient and the Role of anti-CD38 Therapy

Read full text Summarise with VIRAT
Authors: Gabriele Mortari, Andrea Angeletti, Decimo Silvio Chiarenza, Carolina Bigatti, Katia Mazzocco, Gabriele Gaggero, Barbara Cafferata, Alberto Magnasco
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Plasma cell-rich acute rejection (PCAR) is a rare form of kidney allograft rejection characterized by prominent interstitial plasma cell infiltration. It is associated with poor graft outcomes, and its optimal management remains undefined. We report the case of a young patient with PCAR treated with daratumumab, resulting in significant histological improvement.

Fields of Study & Subjects

Renal Transplantation Outcomes and Treatments Transplantation: Methods and Outcomes Organ and Tissue Transplantation Research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105488–105488
Publication date
25 March 2026
Language
EN